Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Pet Cancer Therapeutics Market Size study, by Therapy (Chemotherapy, Radiation therapy, Immunotherapy, Others), by Animal (Dogs, Cats, Others), by Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, Others), and Regional Forecasts 2021-2027

  • BIZ4599809
  • 200 Pages
  • July 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global pet cancer therapeutics marketis expected to reach $432.8 million by 2027. Global pet cancer therapeutics market is valued approximately at $226.25 million in 2020 and is anticipated to grow with a healthy growth rate of about 9.71% over the forecast period 2021-2027. Pet cancer therapeutics deals with the novel anti-cancer drugsthat are used in the cancer treatment and is capableof suppressingeffects of cancerous cells and restricttheir growth in animals such as cats, dogs, etc. The global pet cancer therapeutics marketis being driven by prevalence of several types of cancers in cats and dogs and increase in animal health awareness. Furthermore, there have been different initiatives taken place for research and developmentregarding pet cancer management whichwill provide new opportunities for the global pet cancer therapeutics industry. For instance, according to the American Association for the Advancement of Science, in 2021, a research driven pharmaceutical company named Merck Animal Health has granted $0.1 million to Morris Animal Foundation to support research in animal cancer that would help to advance animal cancer care. Also, in 2017, the University of Queensland received a grant worth $2.5 million from the Australian Cancer Research Foundation (ACRF)for the examination of effects of small doses of anti-cancer drugs in animal as well as human cancers at a cellular level.Such research and development activities related topet cancer management is expected to drive the market by increasing the adoption of pet cancer therapeutics. However,side effects caused by drugs used for the treatment of pet cancersmay impede market growth over the forecast period of 2021-2027.

The regional analysis of the global pet cancer therapeutics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to increasing pet adoption, growth in per capita animal healthcare expenditure, prevalence of different animal diseases and injuries, etc. in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing awareness as well as availability of different pet cancer medicine etc. across the region.

Major market player included in this report are:

AB Science

AdvaVet Inc.

Boehringer Ingelheim GmbH (Merial)

Elanco

ELIAS Animal Health

Karyopharm Therapeutics, Inc.

Rhizen Pharmaceuticals SA

Torigen Pharmaceuticals Inc.

VetDC Inc.

Virbac

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

Chemotherapy

Radiation therapy

Immunotherapy

Others

By Animal:

Dogs

Cats

Others

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Pet Cancer Therapeutics Marketin Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)

1.2.1. Pet Cancer Therapeutics Market, by Region, 2019-2027 (USD Million)

1.2.2. Pet Cancer Therapeutics Market, by Therapy,2019-2027 (USD Million)

1.2.3. Pet Cancer Therapeutics Market, by Animal,2019-2027 (USD Million)

1.2.4. Pet Cancer Therapeutics Market, by Application, 2019-2027 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Pet Cancer Therapeutics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Pet Cancer Therapeutics Market Dynamics

3.1. Pet Cancer Therapeutics Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Prevalence of several types of cancers in cats and dogs

3.1.1.2. Increase in animal health awareness

3.1.2. Market Restraint

3.1.2.1. Side effects caused by drugs used for the treatment of pet cancers

3.1.3. Market Opportunities

3.1.3.1. R&D initiatives regarding pet cancer management

Chapter 4. Global Pet Cancer Therapeutics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Pet Cancer Therapeutics Market, by Therapy

a. Market Snapshot

5.1. Global Pet Cancer Therapeutics Market by Therapy, Performance - Potential Analysis

5.2. Global Pet Cancer Therapeutics Market Estimates & Forecasts byTherapy 2018-2027 (USD Million)

5.3. Pet Cancer Therapeutics Market, Sub Segment Analysis

5.3.1. Chemotherapy

5.3.2. Radiation therapy

5.3.3. Immunotherapy

5.3.4. Others

Chapter 6. Global Pet Cancer Therapeutics Market, by Animal

6.1. Market Snapshot

6.2. Global Pet Cancer Therapeutics Market by Animal, Performance - Potential Analysis

6.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Animal 2018-2027 (USD Million)

6.4. Pet Cancer Therapeutics Market, Sub Segment Analysis

6.4.1. Dogs

6.4.2. Cats

6.4.3. Others

Chapter 7. Global Pet Cancer Therapeutics Market, by Application

7.1. Market Snapshot

7.2. Global Pet Cancer Therapeutics Market by Application, Performance - Potential Analysis

7.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Application 2018-2027 (USD Million)

7.4. Pet Cancer Therapeutics Market, Sub Segment Analysis

7.4.1. Lymphoma

7.4.2. Mast Cell Cancer

7.4.3. Melanoma

7.4.4. Mammary and Squamous Cell Cancer

7.4.5. Others

Chapter 8. Global Pet Cancer Therapeutics Market, Regional Analysis

8.1. Pet Cancer Therapeutics Market, Regional Market Snapshot

8.2. North America Pet Cancer Therapeutics Market

8.2.1. U.S.Pet Cancer Therapeutics Market

8.2.1.1. Therapy breakdown estimates & forecasts, 2018-2027

8.2.1.2. Animal breakdown estimates & forecasts, 2018-2027

8.2.1.3. Applicationbreakdown estimates & forecasts, 2018-2027

8.2.2. CanadaPet Cancer Therapeutics Market

8.3. Europe Pet Cancer Therapeutics Market Snapshot

8.3.1. U.K. Pet Cancer Therapeutics Market

8.3.2. Germany Pet Cancer Therapeutics Market

8.3.3. France Pet Cancer Therapeutics Market

8.3.4. Spain Pet Cancer Therapeutics Market

8.3.5. Italy Pet Cancer Therapeutics Market

8.3.6. Rest of EuropePet Cancer Therapeutics Market

8.4. Asia-PacificPet Cancer Therapeutics Market Snapshot

8.4.1. China Pet Cancer Therapeutics Market

8.4.2. India Pet Cancer Therapeutics Market

8.4.3. JapanPet Cancer Therapeutics Market

8.4.4. Australia Pet Cancer Therapeutics Market

8.4.5. South Korea Pet Cancer Therapeutics Market

8.4.6. Rest of Asia PacificPet Cancer Therapeutics Market

8.5. Latin America Pet Cancer Therapeutics Market Snapshot

8.5.1. Brazil Pet Cancer Therapeutics Market

8.5.2. Mexico Pet Cancer Therapeutics Market

8.6. Rest of The World Pet Cancer Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. AB Science

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. ProductSummary

9.2.1.5. Recent Developments

9.2.2. AdvaVet Inc.

9.2.3. Boehringer Ingelheim GmbH (Merial)

9.2.4. Elanco

9.2.5. ELIAS Animal Health

9.2.6. Karyopharm Therapeutics, Inc.

9.2.7. Rhizen Pharmaceuticals SA

9.2.8. Torigen Pharmaceuticals Inc.

9.2.9. VetDC Inc.

9.2.10. Virbac

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

TABLE 2. Global Pet Cancer Therapeutics Market, report scope

TABLE 3. Global Pet Cancer Therapeutics Market estimates & forecasts by region 2018-2027 (USD Million)

TABLE 4. Global Pet Cancer Therapeutics Market estimates & forecasts by Therapy2018-2027 (USD Million)

TABLE 5. Global Pet Cancer Therapeutics Market estimates & forecasts by Animal2018-2027 (USD Million)

TABLE 6. Global Pet Cancer Therapeutics Market estimates& forecasts by Application 2018-2027 (USD Million)

TABLE 7. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 8. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 9. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 10. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 11. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 12. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 13. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 14. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 15. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 16. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 17. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 18. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 19. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 20. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 21. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)

TABLE 22. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)

TABLE 23. U.S. Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 24. U.S. Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 25. U.S. Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 26. Canada Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 27. Canada Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 28. Canada Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 29. UK Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 30. UK Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 31. UK Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 32. Germany Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 33. Germany Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 34. Germany Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 35. FrancePet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 36. FrancePet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 37. FrancePet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 38. SpainPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 39. SpainPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 40. SpainPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 41. ItalyPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 42. ItalyPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 43. ItalyPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 44. ROE Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 45. ROE Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 46. ROE Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 47. China Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 48. China Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 49. China Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 50. India Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 51. India Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 52. India Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 53. Japan Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 54. Japan Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 55. Japan Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 56. AustraliaPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 57. AustraliaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 58. AustraliaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 59. South KoreaPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 60. South KoreaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 61. South KoreaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 62. ROPAC Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 63. ROPAC Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 64. ROPAC Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 65. Brazil Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 66. Brazil Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 67. Brazil Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 68. Mexico Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 69. Mexico Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 70. Mexico Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 71. ROLA Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 72. ROLA Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 73. ROLA Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 74. ROW Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)

TABLE 75. ROW Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 76. ROW Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)

TABLE 77. List of secondary sources used in the study of global Pet Cancer Therapeutics Market.

TABLE 78. List of primary sources used in the study of global Pet Cancer Therapeutics Market.

TABLE 79. Years considered for the study.

TABLE 80. Exchange rates considered.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research